Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis

Journal of Child Neurology

Volumn 14, Issue 7, 1999, Pages 418-421

  Tekgül, Hasan ^a   Tutuncuoglu, Sarenur ^a   Kutukçuler, Necil ^a   Dizdarer, G ^a   Huseyinov, A ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; MEASLES ANTIBODY; METHISOPRINOL; SALICYLIC ACID; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CASE REPORT; CELLULAR IMMUNITY; CEREBROSPINAL FLUID; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; FLOW CYTOMETRY; HEADACHE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; SUBACUTE SCLEROSING PANENCEPHALITIS; T LYMPHOCYTE;

EID: 0032811965     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389901400702     Document Type: Article

References (22)

1. Risk WS, Haddad FS: The variable natural history of subacute sclerosing panencephalitis: A study of 118 cases from the Middle East. Arch Neurol 1979;36:610-614.
2. Yalaz K, Anlar B, Renda Y, et al: Subacute sclerosing panencephalitis in Turkey: Epidemiological features. J Trop Pediatr 1988; 34:301-305.
3. Gascon G: Treatment of subacute sclerosing panencephalitis. J Child Neurol 1997;12:469-470.
4. Aysun S, Sanal O, Renda Y, et al: Cell mediated immunity in patients with subacute sclerosing panencephalitis. Brain Dev 1984;6:391-396.
5. Marrosu MG, Cianchetti C, Tondi M, et al: Lymphocyte subpopulation in blood and cerebrospinal fluid from patients with subacute sclerosing panencephalitis. Acta Neurol Scand 1983;67:55-63.
6. Marrosu MG, Ennas MG, Murru MR, et al: Surface markers on lymphocytes from human cerebrospinal fluid. Identification by monoclonal antibodies. J Neuroimmunol 1983;5:325-331.
7. Nagano I, Nakamura S, Yoshioka M, Kogure K: Immunocyto-chemical analysis of the cellular infiltrate in brain lesions in subacute sclerosing panencephalitis. Neurology 1991;41:1639-1642.
8. Mehta PD, Kulczycki J, Mehta SP, et al: Increased levels of interleukin-1 beta and soluble intercellular adhesion molecule-1 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis. J Infect Dis 1997;175:689-692.
9. Piotrowska K, Korlak J, Kruszewska J, et al: Secretion of tumor necrosis factor alpha (TNF-α) by peripheral blood monocytes in patients with multiple sclerosis panencephalitis. Neurol Neurochir Pol 1991;25:455-459.
10. Gascon G, Yamani S, Crowell J, et al: Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis. Brain Dev 1993;15:346-355.
11. Yalaz K, Anlar B, Oktem F, et al: Intraventricular Interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology 1992;42:488-491.
12. Anlar B, Yalaz K, Oktem F, Kose G: Long-term follow-up of patient with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon. Neurology 1997;48:526-528.
13. Haddad FS, Risk WS: Isoprinosine treatment in 18 patients with SSPE: A controlled study. Ann Neurol 1980;7:185-188.
14. Fayad MN, Bassem IY, Salman M: Alpha-interferon in the treatment of subacute sclerosing panencephalitis. J Child Neurol 1997;12:486-488.
15. Dyken PR, Dotson PM, Maerentes P: The neurological disability index (NDI) in subacute sclerosing panencephalitis (SSPE), in Bergamini F, Defanti CA, Ferrante P (eds): Subacute Sclerosiny Panencephalitis: A Reappraisal. New York, Elsevier, 1986, pp 109-116.
16. Hanahan DJ, Weintraub ST Platelet-activating factor isolation, identification and assay. Methods Biochem Anal 1985;31:195-258.
17. Hannet I, Erkeller-Yuksel F, Lydyard P, et al; Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today 1992;13:215-218.
18. Ohno R: Interferons in the treatment of multiple myeloma Int J Cancer 1987;1:14-20.
19. Anlar B, Yalaz K, Imir T, Turanli G: The effect of inosiplex in subacute sclerosing panencephalitis: A clinical and laboratory study Eur Neurol 1994;34:44-47.
20. Dhib JS, Jacobsen S, McFarlin DE, McFarlin HF: Impaired human leukocyte antigen-restricted measles in virus-specific cytotoxic-T-cell response in subacute sclerosing panencephalitis. Ann Neurol 1989;25:272-280.
21. Arditi M, Manogue KR, Caplan M, Yogev R: Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis 1990:162:139-147.
22. Jabbour JT, Duenas DA, Sever JL, et al: Epidemiology of subacute sclerosing panencephalitis (SSPE). A report of the SSPE registry. JAMA 1972;220:959-962.